Artificial Intelligence In Industry With Dan Faggella

Today’s guest is Daniel Ferrante, AI Leader in R&D and Data Strategy at Deloitte. Together with Emerj CEO and Head of Research Daniel Faggella, they delve into the complex challenges in AI adoption that major pharmaceutical firms encounter with cultural shifts, technological complexities, and the difficulties in monetizing data and aligning teams efficiently. Additionally, the pair explores the future landscape of phenotypical drug discovery, drawing insights from the context of COVID-19. Their focus underscores the critical importance of collecting and analyzing data to yield actionable insights, especially in the healthcare sector and amidst global health crises. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today’s guest is Bikalpa Neupane, Head of AI/GenAI and Natural Language Processing at Takeda. Bikalpa returns to the program to talk about the difference between a legacy enterprise culture and a data-based enterprise culture, showing how legacy leaders in sectors as diverse as healthcare, financial services, manufacturing, and beyond can make the transition in today’s AI-driven global economy along the way. Later, he and Emerj Senior Editor Matthew DeMello pull apart challenges for large enterprises as more open-source AI tools become available to individuals, eroding the traditional and structural advantages legacy firms have long held in the marketplace. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today’s guest is Craig Mackereth, Executive Vice President of Global Service Delivery at Rimini Street. Rimini Street is a publicly traded company specializing in third-party support for mission-critical systems for financial services organizations and beyond. Craig joins Emerj Senior Matthew DeMello on today’s program to discuss the most significant challenges currently facing financial services leaders when it comes to driving the IT systems and infrastructure necessary to take advantage of data-heavy generative AI use cases. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.

Today’s guests are Anton Kornienko and Ben Webster of NLP Logix, where Anton serves as Data Science Platform Architect and Ben serves as Modeling and Analytics Team Lead. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. Ben and Anton join us on today’s program to offer Emerj’s executive podcast audience advice on the essentials of turning large language models into business value. Throughout the episode, the pair underscore what they see as the biggest misconceptions about LLMs in the media hype cycle and how leaders can find a balance between foundational and bespoke models for different workflows. This episode is sponsored by NLP Logix. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Nadeem Saeed, Corporate Vice President of Digital Transformation and Operational Excellence at Verizon. He joins Emerj Senior Editor Matthew DeMello on this week’s podcast to discuss the biggest challenges that telecom leaders face when it comes to driving infrastructure advances from a consumer and carbon standpoint. Later, they take a closer look at the lessons that startups can learn from more prominent telecom players and vice versa when it comes to strategizing AI deployments in the enterprise. A quick note that the views Nadeem expresses on today’s show are entirely his own and not a reflection of the opinions or views of Verizon as an organization. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today's guest is Steven Zhang, Managing Director at Deloitte Consulting. Steven joins Emerj Senior Editor Matthew DeMello on today's podcast to discuss AI's impact on life sciences IT workflows. Steven introduces this episode by offering a four-pillar framework for rapidly adopting generative AI for life sciences enterprises. He then explains the sector-specific talent needs of adoption teams, underscoring the responsible AI practices and executive buy-in tactics that lead effective digital transformations in almost any industry. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Anuj Maniar, a principal at Deloitte specializing in financial services. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to discuss the dynamics of balancing customer expectations in channel strategy for financial institutions. Later, they discuss emerging AI use cases throughout the multichannel space, including after-call work in customer service. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Poonam Goyal, Sector Head and Senior eCommerce and Athleisure Analyst at Bloomberg Intelligence. Given post-pandemic retail and logistics trends, athleisure is frequently a ‘canary in the coal mine’ for many business challenges across supply chains and online marketing. She joins Emerj Senior Editor Matthew DeMello to talk about the eCommerce space more broadly through the lens of athleisure and how AI capabilities are helping to solve many of these challenges. To access Emerj’s frameworks for AI readiness, ROI, and strategy, visit Emerj Plus at emerj.com/p1.

Today’s is an exceptional episode of the AI in Business podcast. This week, we are delighted to announce the launch of ‘The Trajectory,’ a new video channel, podcast, and newsletter from Emerj Technology Research. As a special sneak preview of the first episode of the podcast, we’re featuring a portion of our conversation with revered computer scientist and University of Montreal professor Yoshua Bengio on today’s episode of the ‘AI in Business’ podcast. In conversation with Emerj CEO and Head of Research Daniel Faggella, the ‘Trajectory’ sneak preview marks Yoshua’s return to the ‘AI in Business’ podcast for the first time in nearly a decade to explain his recent and very openly declared change of heart on the implications of artificial general intelligence (AGI) on the global realpolitik, and how large language models like ChatGPT became the catalyst for that change.

Today’s guest is Laks Pernenkil, a principal in life sciences consulting at Deloitte. Laks joins Emerj CEO and Head of Research Daniel Faggella on today’s show to discuss AI in pharmaceutical supply chain manufacturing, showcasing a host of AI use cases and applications across manufacturing and operational lines of business. Later, the two surmise the near future of AI adoption in pharmaceutical supply chain management and where business leaders should focus their investments and attention. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guests are Karl Hersch, Vice Chairman and leader of Deloitte’s US Insurance practice, and Sandee Suhrada, Partner at Monitor Deloitte leading AI for Insurance. They join Emerj CEO and Head of Research Daniel Faggella on today’s podcast to discuss the opportunity space in insurance, highlighting the integration of automation and potential value for business creation. Throughout the episode, the pair underscore incoming changes to underwriting and customer engagement workflows, focusing on performance, productivity, and efficiency plays over the next three years. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Shane Bray, Chief Customer Experience Officer (CXO) at Blue Cross and Blue Shield of Louisiana. He joins Emerj Senior Editor Matthew DeMello on today’s program to examine how the convergence of healthcare and financial services presents a compelling opportunity for the integration of AI to elevate patient experiences and customer interactions in insurance workflows. Later, they take a closer look at the advantages of generative AI in addressing problems like the interoperability of different healthcare IT systems and giving caretakers a deeper understanding of patient behaviors and sentiment analysis. This episode is sponsored by Uniphore. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Adam Burns, Vice President of Network and Edge and director of EdgeAI Development Tools at Intel. Adam returns to the podcast this week to talk about out-of-the-box solutions for computer vision in manufacturing, retail, healthcare, and beyond. Throughout the episode, Adam discusses relevant use cases related to Intel’s Geti Platform, what industry leaders should know before deploying out-of-the-box AI products, and the essential lessons in model development he’s gained from developing these tools. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Today’s guest is Gianni Giacomelli, Former Senior Advisor for Innovation at Genpact. Gianni currently serves as Head of Design Innovation at the Collective Intelligence Design Lab at MIT. He served as Chief Innovation Officer at Genpact from 2016 to 2022, when he stepped down to found Supermind. Design, an innovation advisory firm that helps organizations engaged in environmental and social transformation harness the power of AI tools. Gianni joins us on today’s program for a sober yet optimistic conversation with Emerj CEO and Head of Research Daniel Faggella on the real-world implications for generative AI, the massive changes it will bring about for multiple industries in the near future, and what business leaders need to know to thrive in the new landscape. For more relevant insights on these topics, business leaders should also explore Genpact’s recent white paper titled ‘Break Boundaries with Generative AI.’ This episode is sponsored by Genpact. Learn how brands work with Emerj and other Emerj Media opt

Today’s guests include Kelly Cusick, Managing Director in Deloitte Consulting’s Actuarial & Insurance Solutions practice, and Michael Cline, Managing Director and Insurance Sector Claims Leader for Deloitte Consulting. Joining Emerj Senior Editor Matthew DeMello, they explain key trends in underwriting for our executive audience, emphasizing the evolution of personalization and the expanding reach of personal connections within the industry. Later in the discussion, the trio explores the transformative impact of new AI capabilities, shedding light on how these technologies enable insurance companies to streamline workflows and provide invaluable prescriptive insights for both underwriters and customers alike. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guest is Andrew Bolt, Partner at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to talk about challenges in R&D  for life sciences. While productivity has remained stagnant for the last 10-15 years, advances in AI-enhanced protein structure prediction are revolutionizing drug targeting and the very infrastructure of recruiting patients for clinical trials. Later, the two postulate on the ways AI can expedite regulatory compliance in pharmaceutical R&D in similar ways. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

Today’s guests on the ‘AI in Business’ podcast are Jennifer Bradshaw and Arash Kamiar, Director of Product and Senior Product Owner at NLP Logix, respectively. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. They join Emerj Senior Matthew DeMello on today’s podcast to talk about developing AI solutions with what they call a ‘product mindset.’ Throughout the program, the pair emphasize shifting focus away from the unique technological capabilities of AI tools to the problems that customers suffer through every day and how those tools can be applied to solve them. This episode is sponsored by NLP Logix. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

Today’s guest is Dr. Dan Elton, a Data Scientist at the Mass General Brigham Data Science Office. He’s also a fellow at the Foresight Institute and previously served as a staff scientist at the National Institutes of Health. He joins Emerj Senior Editor Matthew DeMello on today’s show to talk about promising AI use cases in healthcare, including use cases in radiology, compliance, and medical record generation, search, and summarization. Later, the two discuss how foundational models will transform how AI is used in radiology. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.

Today's guest is Bhuvanesh Abrol, US Private Equity Consulting Leader and US M&A Services Private Equity Consulting Leader at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today's program to talk about the AI opportunities in private equity investment decisions and deal-making. Later, the pair pull apart the fundamentals of using AI to inform opaque pricing in procurement and to drive increased collection rates. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Today’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies and Vinita Navadgi, Sr. Director, Digital Patient Suite at IQVIA. They join us on today’s show to discuss the advantages of optimizing consent workflows through automation, or ‘eConsent’ processes. The conversation delves into the metrics defining the effectiveness of ‘eConsent’ for both patients and healthcare providers, elucidating the role of AI in shaping the broader landscape of clinical trials. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!